Abstract
Cancer arises as the result of sequential alterations in growth-controlling genes. Epigenetic factors, such as angiogenesis and surrounding micro-environment can also affect cancer initiation and progression. Tumorigenesis is accompanied by important changes in gene expression in the tumor cell as compared to its normal counterpart. The advent of powerful new techniques such as microarray technology and SAGE has allowed the study of gene expression in neoplastic cells at a scale never before accomplished. Indeed, it is now possible to efficiently measure the levels of thousands of genes expressed in normal and tumor tissues. This global knowledge of gene expression allows the identification of differentially expressed genes and, in principle, the understanding of the complex molecular circuitry regulating normal and neoplastic growth. Such studies have led to molecular profiling of tumors, which have suggested general methods for distinguishing tumors of various biological behaviors (molecular classi fication), elucidating pathways relevant to the tumorigenesis process, and identifying targets for the detection (biomarkers) and mechanism-based therapy of cancer. The next challenge will be the implementation of these breakthroughs in the clinic, as well as the extension of these paradigms to the fields of proteomics and physiomics.
Current Genomics
Title: Functional Genomics Approaches in Cancer Research
Volume: 3 Issue: 5
Author(s): Patrice J. Morin
Affiliation:
Abstract: Cancer arises as the result of sequential alterations in growth-controlling genes. Epigenetic factors, such as angiogenesis and surrounding micro-environment can also affect cancer initiation and progression. Tumorigenesis is accompanied by important changes in gene expression in the tumor cell as compared to its normal counterpart. The advent of powerful new techniques such as microarray technology and SAGE has allowed the study of gene expression in neoplastic cells at a scale never before accomplished. Indeed, it is now possible to efficiently measure the levels of thousands of genes expressed in normal and tumor tissues. This global knowledge of gene expression allows the identification of differentially expressed genes and, in principle, the understanding of the complex molecular circuitry regulating normal and neoplastic growth. Such studies have led to molecular profiling of tumors, which have suggested general methods for distinguishing tumors of various biological behaviors (molecular classi fication), elucidating pathways relevant to the tumorigenesis process, and identifying targets for the detection (biomarkers) and mechanism-based therapy of cancer. The next challenge will be the implementation of these breakthroughs in the clinic, as well as the extension of these paradigms to the fields of proteomics and physiomics.
Export Options
About this article
Cite this article as:
Morin J. Patrice, Functional Genomics Approaches in Cancer Research, Current Genomics 2002; 3 (5) . https://dx.doi.org/10.2174/1389202023350309
DOI https://dx.doi.org/10.2174/1389202023350309 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Telomerase Modulation in Therapeutic Approach
Current Pharmaceutical Design Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges
Current Clinical Pharmacology The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
Current Medicinal Chemistry Cannabinoids, Immune System and Cytokine Network
Current Pharmaceutical Design Promises of Apoptosis-Inducing Peptides in Cancer Therapeutics
Current Pharmaceutical Biotechnology Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Current Pharmaceutical Design A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
Current Pharmaceutical Design Recent Advances of MEK Inhibitors and Their Clinical Progress
Current Topics in Medicinal Chemistry dUTPase in Human Neoplastic Cells as a Potential Target for Therapeutic Intervention
Current Protein & Peptide Science Advances in the Researches on the Biological Activities and Inhibitors of Phosphatidylinositol 3-kinase
Anti-Cancer Agents in Medicinal Chemistry Ferroptosis: A Novel Mechanism of Artemisinin and its Derivatives in Cancer Therapy
Current Medicinal Chemistry Treatment of Diffuse-Type Gastric Cancer Cells Using 213Bi-Radioimmunoconjugates In Vitro and In Vivo Following Intraperitoneal Dissemination
Current Radiopharmaceuticals TNF-Related Apoptosis-Inducing Ligand (TRAIL) as a Pro-Apoptotic Signal Transducer with Cancer Therapeutic Potential
Current Pharmaceutical Design Radiolabelled Molecules for Imaging the Translocator Protein (18 kDa) Using Positron Emission Tomography
Current Medicinal Chemistry Targeting ErbB Receptors in High-Grade Glioma
Current Pharmaceutical Design Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer
Current Cancer Drug Targets Modulation of Matrix Metalloproteinases by Plant-derived Products
Current Cancer Drug Targets miR-221/222 Confers Radioresistance in Glioblastoma Cells Through Activating Akt Independent of PTEN Status
Current Molecular Medicine Resveratrol and Lifespan in Model Organisms
Current Medicinal Chemistry Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued)